Novozymes A/S
OTC:NVZMF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Novozymes A/S
OTC:NVZMF
|
DK |
|
P
|
PTC Therapeutics Inc
XBER:BH3
|
US |
|
Henderson Land Development Co Ltd
HKEX:12
|
HK |
|
A
|
ArcelorMittal SA
F:ARRD
|
LU |
|
C
|
China Longyuan Power Group Corp Ltd
F:6WX
|
CN |
|
F
|
Factset Research Systems Inc
SWB:FA1
|
US |
|
Westwing Group SE
XETRA:WEW
|
DE |
|
Brown-Forman Corp
F:BF5A
|
US |
|
P
|
Packaging Corp of America
XMUN:PKA
|
US |
|
Asics Corp
TSE:7936
|
JP |
|
Barrick Gold Corp
TSX:ABX
|
CA |
|
G
|
Garmin Ltd
XBER:GEY
|
CH |
|
S
|
Subsea 7 SA
XBER:SOC
|
UK |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NVZMF's stock price target?
Not Available
NVZMF does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Novozymes A/S?
Projected CAGR
-55%
Over the last 7 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 2 years is -55%.
What is the Net Income forecast for Novozymes A/S?
Projected CAGR
-56%
Over the last 7 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 2 years is -56%.